Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Best match
Most recent
newsroom.csl
2d
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Temporary marketing authorization is based on statistically significant and clinically meaningful results from the phase-III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Reaches tentative union deal
Judge unseals new evidence
Philip Zimbardo dies at 91
Netanyahu's home targeted
Challenges military listing
Probes near miss in Austin
Calif. oil refinery closure
NK sending troops to RU?
PG&E shuts off power
School shooting report
NC breaks turnout record
Fire prompts evacuations
Three Americans detained
La Nina could arrive soon
US deficit reaches $1.8T
Republicans appeal ruling
Frozen waffles recalled
Ex-MN congressman dies
Bladder cancer drug pulled
Emergency abortion ruling
At decade-high level
To furlough 700 workers
OK classroom Bible suit
$4M LAPD fentanyl seizure
G7 ministers back Ukraine
Nationwide blackout in Cuba
Opioid suits settlement deal
Antitrust ruling delayed
Feedback